Skin Cleanser, 500mg Capsules, 90-count bottles2, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808
Herbal Doctor Remedies
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
💊 Drugs • 11,927 recalls
Herbal Doctor Remedies
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Innovative Intrathecal Solutions, Inc.
Lack of Assurance of Sterility
Herbal Doctor Remedies
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Herbal Doctor Remedies
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Teva Pharmaceuticals USA
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Herbal Doctor Remedies
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Medical Center Pharmacy
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
Lupin Pharmaceuticals
Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.
Failed Impurities/Degradation Specification: Presence of unknown impurity observed.
Medical Center Pharmacy
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
Medical Center Pharmacy
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
Medical Center Pharmacy
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
Medical Center Pharmacy
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing.
Dr. Reddy's Laboratories
Defective Container: Recall is due to breaking and shattering of ampules upon opening
Nostrum Laboratories
CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.
Failed Stability Specifications
Mylan Pharmaceuticals
Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.
Glaxosmithkline Consumer Healthcare Holdings
Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.
Glaxosmithkline Consumer Healthcare Holdings
Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.